EMA — authorised 25 September 2013
- Status: approved
🇪🇺 Gilotrif in European Union
EMA authorised Gilotrif on 25 September 2013
Marketing authorisation
Gilotrif in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Gilotrif approved in European Union?
Yes. EMA authorised it on 25 September 2013.
Who is the marketing authorisation holder for Gilotrif in European Union?
Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.